DH and TH lymphomas in the Mitelman database
| DH lymphomas . | N . | Percentage of all 326 DH cases . | MYC-IG fusion, % . | MYC-IGK or IGL fusion (% of cases with MYC-IG fusion)* . |
|---|---|---|---|---|
| BCL2+/MYC+ | 203 | 62 | 66 | 49 |
| BCL6+/MYC+ | 26 | 8 | 31 | 13 |
| BCL2+/BCL6+/MYC+ | 53 | 16 | 53 | 50 |
| CCND1+/MYC+ | 34 | 10 | 20 | 43 |
| BCL3+/MYC+ | 5 | 2 | ||
| 9p13+/MYC+ | 4 | 1 | ||
| BCL3+/9p13+/MYC+ TH | 1 | 0 | ||
| Total DH and TH cases | 326 | 100 | ||
| MYC only | ||||
| Burkitt lymphoma | 205 | 98 | 18 | |
| Other lymphomas | 158 | 61 | 34 | |
| Total | 689 |
| DH lymphomas . | N . | Percentage of all 326 DH cases . | MYC-IG fusion, % . | MYC-IGK or IGL fusion (% of cases with MYC-IG fusion)* . |
|---|---|---|---|---|
| BCL2+/MYC+ | 203 | 62 | 66 | 49 |
| BCL6+/MYC+ | 26 | 8 | 31 | 13 |
| BCL2+/BCL6+/MYC+ | 53 | 16 | 53 | 50 |
| CCND1+/MYC+ | 34 | 10 | 20 | 43 |
| BCL3+/MYC+ | 5 | 2 | ||
| 9p13+/MYC+ | 4 | 1 | ||
| BCL3+/9p13+/MYC+ TH | 1 | 0 | ||
| Total DH and TH cases | 326 | 100 | ||
| MYC only | ||||
| Burkitt lymphoma | 205 | 98 | 18 | |
| Other lymphomas | 158 | 61 | 34 | |
| Total | 689 |
MYC+ indicates 8q24 breakpoint; BCL2+, 18q21; BCL6+, 3q27; CCND1+, 11q13; BCL3+, 19q13; and 9p13+, yet unidentified locus.
One case had a complex t(8;14;22)(q24;q32;q11), another case both a t(8;14)(q24;q32) and t(8;22)(q24;q11). Arbitrarily, both cases were considered as having two MYC-IG events.